Article Data

  • Views 1120
  • Dowloads 135

Case Reports

Open Access

Immunohistochemical investigation of p-53, C-NEU and EGFR expression in HPV-related epidermoid endometrial carcinoma

  • A. Kondi-Pafiti1,*,
  • E. Kairi-Vassilatou1
  • M. Frangou-Plemenou1
  • C. Dimopoulou1
  • M. Englezou1
  • K. Sykiotis1

1Pathology Department, Greece

22nd Clinic of Gynecology and Obstetrics, Areteion Hospital, Athens University, Athens, Greece

DOI: 10.12892/ejgo20020170 Vol.23,Issue 1,January 2002 pp.70-71

Published: 10 January 2002

*Corresponding Author(s): A. Kondi-Pafiti E-mail:

Abstract

Epidermoid carcinoma (PSCC) of the endometrium is a rare form of endometrial cancer that constitutes about 0.1% of all malignant epithelial tumors of the uterus. The diagnosis of PSCC is based on strict criteria and is made in the absence of a glandular component of the tumor. Squamous cell carcinoma of the endometrium should enter the differential diagnosis in postmenopausal patients in the presence of atypical squamous cells in the uterine curettage, while the cervical biopsies are negative for malignancy. The presence of HPV should be investigated as well, so that its pathogenetic relation is clarified. While no significant relation was found to p-53, C-NEU and EGFR expression this investigation must be continued because. HPV may interact with tumor suppressor genes.

Keywords

Epidermoidal endometrial carcinoma; Squamous cell carcinoma; HPV; p-53; C-NEU; EGFR

Cite and Share

A. Kondi-Pafiti,E. Kairi-Vassilatou,M. Frangou-Plemenou,C. Dimopoulou,M. Englezou,K. Sykiotis. Immunohistochemical investigation of p-53, C-NEU and EGFR expression in HPV-related epidermoid endometrial carcinoma. European Journal of Gynaecological Oncology. 2002. 23(1);70-71.

References

[1] Abel er V. M., Kjorstad K. E., Berle E.: "Carcinoma of endometrium in Norway. A histopathological and prognostic survey of a total population". Int. J. Gynecol. Cancer, 1992, 2, 9.

[2] Blausteins: "Pathology of the Female Genital Tract". 4'" ed., (ed.) Kurman R.J., New York: Springer-Verlag, 1994, 439.

[3] Silvenberg S. G., Kurman R. J.: "Atlas of Tumor Pathology No 3". Third Series. "Tumor of the uterine corpus and gestational trophoblastic disease". Pub!. AFIP, USA, 1992, 47.

[4] Simon A., Kopolovic J., Beyth Y.: "Primary squamous cell carcinoma of the endometrium". Gynecol. Oncol., 1998, 31, 454.

[5] Scheffner M., Werness B. A., Huibregtse J.M., Levine A. J., Howley P. M.:'The E6 oncoprotein encoded by human papilloma virus types 16 and 18 promotes the degradation of p-53". Cell, 1990, 63, 1129.

[6] Couturier J., Sastre- Garau X., Schneider-Maunoury S., Labib A., Orth G.: "Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression". J. Virol., 1991, 65, 4534

[7] Melin J. R., Wanner L., Schultz D. M., Kassell E. E.: "Pnmary squamous cell carcinoma of the endometrium". Obstet. Gynecol., 1979, 53, 115.

[8] Sluijmer A. V., Ubachs J.M. H., Stoot J.E. G. M. et al.: "Clinical and pathological aspects of benign and malignant squamous epithelium of the corpus uteri: a report of two cases". Eur. J. Obstet. Gynecol. Reprod. Biol., 1991, 39, 71.

[9] Wilbur D. C., Bonfiglio T. A., Stoler M. H.: "Continuity of HPV type between neoplastic precursors and invasive cervical carcinoma. An in situ hybridization study". Am. J. Surg. Pathol., 1988, 12, 182.

[10] Crum C. P., Nuovo G. J.: "Invasive genital cancers and papilloma viruses". In: "Genital Papillomavirous and Related Neoplasms" New York, Raven Press, 1991, 167.

[11] Werness B., Levine A., Howley P.: "Association of human papillomavirus types 16 and 18 proteins with p- 53". Science, 1990, 248, 76

[12] Dunn J.M., Phillips R. A., Becker A. J., Gallie B. L.: "ldentification of germline and somatic mutations affecting the retinoblastoma gene". Science, 1988, 241, 1797.

Submission Turnaround Time

Top